Registry for patients with portal hypertension undergoing TIPS
Österreichisches Register (inklusive Biobank) Für Transjuguläre Intrahepatische Portosystemischem Shunts (TIPS): AUTIPS (AUstrian TIPS Study)
This study is looking at patients with serious liver disease who have had a specific procedure called TIPS to see how they do afterwards and if certain markers can help predict any problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna, State of Vienna) |
| Trial ID | NCT03409263 on ClinicalTrials.gov |
What this trial studies
This observational registry study aims to recruit patients with advanced chronic liver disease who are undergoing or have undergone transjugular intrahepatic portosystemic shunt (TIPS) implantation. The study will document the clinical course of these patients and assess biomarkers that may predict complications following the procedure. By collecting and analyzing this data, the study seeks to improve understanding of long-term outcomes associated with TIPS and enhance patient management strategies.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18-99 with portal hypertension who are anticipated to undergo or have previously undergone TIPS implantation.
Not a fit: Patients who retract their consent or do not meet the eligibility criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and management of complications in patients with portal hypertension undergoing TIPS.
How similar studies have performed: While there have been studies on TIPS, this registry approach focusing on long-term outcomes and biomarkers is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-99 years * Portal hypertension * Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS) * Informed consent Exclusion Criteria: * Retraction of consent
Where this trial is running
Vienna, State of Vienna
- Medical University of Vienna — Vienna, State of Vienna, Austria (Recruiting)
Study contacts
- Principal investigator: Thomas Reiberger, MD — Medical University of Vienna
- Study coordinator: Thomas Reiberger, MD
- Email: thomas.reiberger@meduniwien.ac.at
- Phone: +43140400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.